CTRI Number |
CTRI/2020/09/028006 [Registered on: 23/09/2020] Trial Registered Prospectively |
Last Modified On: |
16/09/2020 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda |
Study Design |
Randomized, Parallel Group, Active Controlled Trial |
Public Title of Study
|
Comparative effect of fresh and dry Giloy (Guduchi) in the management of diabetes |
Scientific Title of Study
|
Efficacy of Aardra and Shushka Guduchi [Tinospora cordifolia (Willd) Miers] in the management of Madhumeha (Type-II DM): A Comparative open label Randomized controlled clinical trial |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Niranjan Ram |
Designation |
Post graduate scholar - M.D. Ayu |
Affiliation |
All India Institute of Ayurveda |
Address |
Department of Dravyaguna,
Room No- 219, 211
2nd floor, Academic block
All India Institute of Ayurveda
Gautam Puri Sarita vihar
New Delhi
New Delhi DELHI 110076 India |
Phone |
7978796914 |
Fax |
|
Email |
vaidyaniranjanram@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Prof Dr Tanuja Manoj Nesari |
Designation |
Professor -cum- Director |
Affiliation |
All India Institute of Ayurveda |
Address |
Department of Dravyaguna,
Room No- 218
2nd floor, Academic block
All India Institute of Ayurveda
Gautam Puri Sarita vihar
New Delhi
South DELHI 110076 India |
Phone |
9958817145 |
Fax |
|
Email |
tnesari@hotmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Niranjan Ram |
Designation |
Post graduate scholar - M.D. Ayu |
Affiliation |
All India Institute of Ayurveda |
Address |
Department of Dravyaguna,
Room No- 219, 211
2nd floor, Academic block
All India Institute of Ayurveda
Gautam Puri Sarita vihar
New Delhi
South DELHI 110076 India |
Phone |
07978796914 |
Fax |
|
Email |
vaidyaniranjanram@gmail.com |
|
Source of Monetary or Material Support
|
All India Institute of Ayurveda
Gautam Puri, Sarita vihar
New Delhi -110076 |
|
Primary Sponsor
|
Name |
All India Institute of Ayurveda |
Address |
Gautam Puri Sarita vihar New Delhi |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 2 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Niranjan Ram |
All India Institute of Ayurveda |
Department of Dravyaguna,
2nd floor, Academic block
All India Institute of Ayurveda, Gautam Puri, Sarita Vihar-110076 South DELHI |
07978796914
vaidyaniranjanram@gmail.com |
Prof Dr Tanuja Manoj Nesari |
All India Institute of Ayurveda |
Department of Dravyaguna, 2nd floor , Academic block
All India Institute of Ayurveda, Gautam Puri, Sarita Vihar-110076 South DELHI |
9958817145
tnesari@hotmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
IEC-All India Institute of Ayurveda |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
, (1) ICD-10 Condition: E118||Type 2 diabetes mellitus with unspecified complications, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Glimepiride (1mg) |
Glimepiride (1mg) tablets, 15 minutes before breakfast, once a day or titrate as per blood glucose level |
Intervention |
TCa (Guduchi Ghan tablet prepared from fresh Guduchi) |
TCa tablet - 500 mg twice a day after breakfast and supper, orally with luke warm water, daily for a period of 3 months |
Intervention |
TCs (Guduchi Ghan tablet prepared from dry Guduchi) |
TCs tablet- 500 mg twice a day after breakfast and supper,after breakfast and supper, orally with luke warm water, daily for a period of 3 months |
|
Inclusion Criteria
|
Age From |
25.00 Year(s) |
Age To |
65.00 Year(s) |
Gender |
Both |
Details |
1. Recently diagnosed (less than 1 year of diabetic history) cases of Type-2 DM and not taking any antidiabetic drug/Insulin since 2 months
2. Including both Pre-diabetes and diabetes cases
Fasting Blood Sugar (FBS) ranges between 100 to 125 mg/dl in pre-diabetes and greater than 126 mg/dl to less than equal to 200 mg/dl in diabetes cases.
Post Prandial Blood Sugar (PPBS) ranges between
140 to 199 mg/dl in Pre-diabetes and greater than 200 mg/dl to less than equal to 350 mg/dl in diabetes cases.
HbA1c ranges between 5.7 % to 6.4 % in Pre-diabetes and greater than equal to 6.5 % to less than equal to 8 % in diabetes cases.
3. Presence of urine sugar
4. Frequency of urination 7 to 10 times per 24 hours and quantity and quantity greater than equal to 2500 ml
5. Accidentally diagnosed cases of Type-2 DM who visit the hospital for other complaints |
|
ExclusionCriteria |
Details |
1. Cardiovascular disorder with Type-2 DM
2. Malignant and accelerated Hypertensive
3. Pregnant woman and planning to be pregnant within 6 months
4. Lactating mother
5. Secondary Diabetes Mellitus
6. Patients undergoing regular treatment for diabetes or any other severe illness
7. CNS Disorder e.g. Encephalopathy
8. Subjects already suffering from the complications of Diabetes (Diabetes Nephropathy, Diabetic retinopathy, Diabetic Neuropathy etc.)
9. Poorly controlled Glycemic status (HbA1c greater than 8%)
10. Concurrent serious hepatic dysfunction (AST or ALT greater than 3 times of upper normal limit)
11. Subjects on steroids, oral contraceptives or estrogen replacement therapy
12. Alcoholics and/or drug abusers
13. H/O hypersensitivity to any trial drug
14. Hypothyroidism or hyperthyroidism
15. Patients on vitamin B supplementation
16. Patients under other clinical trials for more than 12 weeks
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
An Open list of random numbers |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
To access clinically the comparative anti-diabetic activity of Aardra (TCa) and Shushka (TCs) Guduchi by assessing the blood glucose level and HbA1c level |
1. Blood Glucose level - 0th day, 15 th day, 30th day, 45 th day, 60 th day, 75 th day, 90th day
2. HbA1c level - 0th day and 90th day |
|
Secondary Outcome
|
Outcome |
TimePoints |
1. Analytical study (HPLC, HPTLC) of TCa and TCs
2. Quality of Life assessment. |
HPLC and HPTLC - 0th
Quality of Life - 0 and 90 th day |
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2/ Phase 3 |
Date of First Enrollment (India)
|
15/10/2020 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
The thesis work will be published in reputed journal after completion. |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
INTRODUCTION -
Diabetes mellitus is a sovereign disease considered as one of the arch-enemies of mankind, resulting due to faulty diet and lifestyle. It is a group of metabolic disorders characterized by hyperglycemia caused by an absolute or relative deficiency of Insulin There are 3 main types of Diabetes mellitus - 1) Type-1 DM 2) Type-2 DM 3) Gestational DM. In Ayurveda texts, the characteristic features of "Madhumeha" shows remarked resemblance with the syndrome of Diabetes Mellitus -2 (Type-2 DM). Madhumeha is a tridoshaja vyadhi but our ancient scholars mainly emphasized on vitiation of Kapha dosha, Medodusthi and Meda dhatwagni mandya. For disintegrating the pathogenesis, there must be a single drug or a formulation at the level of dhatwagni and counteracting Kapha dosha and Meda dhatu.
Guduchi (Tinospora cordifolia) is having Katu-Tikta-Kashaya Rasa, Laghu Guna, Ushna veerya and Tridoshaghna activity which may help in the disintegration of the pathogenesis of Madhumeha. Again in Madhumeha, there is Ojakshyaya (Oja is equivalent to Bala) and Guduchi is having the property of Balya and Rasayana. Regarding the form in which Guduchi is used, classics of Ayurveda have advised using it in "Ardra" (fresh) form but in day to day practice unfortunately it is used in the "Shushka" form. Further, a few works have been reported towards evaluating the efficacy of the classically mentioned use of "Ardra Guduchi". Therefore, a clinical study to compare the anti-diabetic effect of Tinospora cordifolia - ardra (TCa) and Tinospora cordifolia - shushka (TCs) is planned.
OBJECTIVES OF RESEARCH -
1. Primary objective - To assess clinically the comparative anti-diabetic activity of Ardra (TCa) and Shushka (TCs) Guduchi. 2. Secondary objectives - * Analytical study (HPLC, HPTLC) of TCa and TCs. * Quality of Life (QOL) Assessment
METHODOLOGY -
1. Drug Identification - Certification from taxonomist and Dravyaguna specialist will be taken and a voucher specimen will be preserved.
2. Drug Analysis - Analysis of TCa and TCs in HPLC and HPTLC method.
3. Drug Preparation - The drugs are prepared in the college pharmacy or procured from any reputed pharmacy as suitable.
4. Study Design- Three Armed Randomised Standard Controlled Trial.
5. Sample Size = Total 60 ( 20 in each group)
6. Group - A (TCa + Lifestyle modification) - TCa Ghan (aqueous solid extract) tablets, at a dose of 500 mg twice a day orally after breakfast and supper with lukewarm water.
7. Group - B (TCs + Lifestyle modification) - TCs Ghan tablets, at a dose of 500 mg twice a day orally after breakfast and supper with lukewarm water.
8. Group - C (Standard control) (Glimepiride + Lifestyle modification + Placebo capsules of wheat powder) - Glimepiride (1mg) tablets and 1 placebo capsule once a day (or titrate as per blood glucose level) orally 15 minutes before breakfast with water.
9. Duration - 3 months
10. Purpose of the trial - The purpose of the trial is the same as the primary objective of the research i.e. to evaluate clinically the comparative antidiabetic activity of Ardra & Shushka Guduchi (TCa and TCs).
11. Findings if any - As the patient recruitment is not started yet henceforth the findings are going to be evaluated after completion of the study.
12. Publication details - After completion of the thesis work, the study will be published in peer-reviewed journals.
|